Literature DB >> 30485497

Seminal immunologic discoveries with direct clinical implications: The 2018 Nobel Prize in Physiology or Medicine honours discoveries in cancer immunotherapy.

Hans-Gustaf Ljunggren1, Roland Jonsson1, Petter Höglund1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30485497     DOI: 10.1111/sji.12731

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


× No keyword cloud information.
  8 in total

Review 1.  PD-1/PD-L1 pathway: current researches in cancer.

Authors:  Yanyan Han; Dandan Liu; Lianhong Li
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 2.  The gut microbiota can be a potential regulator and treatment target of bone metastasis.

Authors:  Kelly F Contino; Hariom Yadav; Yusuke Shiozawa
Journal:  Biochem Pharmacol       Date:  2022-01-15       Impact factor: 5.858

Review 3.  Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation.

Authors:  Mariana Segovia-Mendoza; Susana Romero-Garcia; Cristina Lemini; Heriberto Prado-Garcia
Journal:  J Immunol Res       Date:  2021-01-07       Impact factor: 4.818

Review 4.  The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy.

Authors:  Wenxiao Jiang; Shuya Pan; Xin Chen; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Mol Cancer       Date:  2021-09-08       Impact factor: 27.401

Review 5.  The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer.

Authors:  Yaping Chen; Xiao Zheng; Changping Wu
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

6.  Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.

Authors:  Kuangxun Li; Junzhe Liu; Xinyu Yang; Zewei Tu; Kai Huang; Xingen Zhu
Journal:  Biosci Rep       Date:  2021-12-22       Impact factor: 3.840

Review 7.  Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer.

Authors:  Yanmeizhi Wu; Shan Yu; Hong Qiao
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

Review 8.  Race, the microbiome and colorectal cancer.

Authors:  Kendra J Royston; Babatunde Adedokun; Olufunmilayo I Olopade
Journal:  World J Gastrointest Oncol       Date:  2019-10-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.